Envestnet Portfolio Solutions Inc. Purchases 10,842 Shares of SPDR S&P Pharmaceuticals ETF $XPH

Envestnet Portfolio Solutions Inc. boosted its position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 6.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 171,930 shares of the company’s stock after purchasing an additional 10,842 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in SPDR S&P Pharmaceuticals ETF were worth $8,242,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in XPH. Park Avenue Securities LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at about $485,000. U.S. Capital Wealth Advisors LLC lifted its holdings in SPDR S&P Pharmaceuticals ETF by 2.6% in the third quarter. U.S. Capital Wealth Advisors LLC now owns 14,730 shares of the company’s stock valued at $706,000 after buying an additional 378 shares during the period. Corient Private Wealth LLC acquired a new position in SPDR S&P Pharmaceuticals ETF in the second quarter valued at approximately $294,000. EP Wealth Advisors LLC bought a new position in SPDR S&P Pharmaceuticals ETF in the second quarter valued at approximately $278,000. Finally, SVB Wealth LLC grew its holdings in SPDR S&P Pharmaceuticals ETF by 24.5% during the 2nd quarter. SVB Wealth LLC now owns 41,012 shares of the company’s stock worth $1,664,000 after acquiring an additional 8,079 shares during the period.

SPDR S&P Pharmaceuticals ETF Stock Performance

Shares of SPDR S&P Pharmaceuticals ETF stock opened at $56.28 on Friday. The firm has a fifty day moving average of $55.38 and a two-hundred day moving average of $49.55. The stock has a market capitalization of $264.52 million, a price-to-earnings ratio of 14.28 and a beta of 0.60. SPDR S&P Pharmaceuticals ETF has a 52 week low of $35.22 and a 52 week high of $58.00.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.